[Federal Register Volume 76, Number 130 (Thursday, July 7, 2011)]
[Notices]
[Page 39879]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-17009]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Clinical Laboratory Improvement Advisory Committee (CLIAC)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned
committee:
Times and Dates: 8:30 a.m.-5 p.m., August 31, 2011.
8:30 a.m.-12 p.m., September 1, 2011.
Place: CDC, 1600 Clifton Road, NE., Tom Harkin Global
Communications Center, Building 19, Room 232, Auditorium B, Atlanta,
Georgia 30333.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 100 people.
Purpose: This Committee is charged with providing scientific and
technical advice and guidance to the Secretary of Health and Human
Services, the Assistant Secretary for Health, and the Director, CDC,
regarding the need for, and the nature of, revisions to the
standards under which clinical laboratories are regulated; the
impact on medical and laboratory practice of proposed revisions to
the standards; and the modification of the standards to accommodate
technological advances.
Matters to be Discussed: The agenda will include agency updates
from the CDC, the Centers for Medicare & Medicaid Services (CMS),
and the Food and Drug Administration (FDA); presentations and
discussions on the laboratory's role in the development and use of
electronic health records, electronic laboratory reporting for
notifiable diseases, and meaningful use; and presentations and
discussion on current practices in gynecologic cytology testing.
Agenda items are subject to change as priorities dictate.
Online Registration Required: In order to expedite the security
clearance process at the CDC Roybal Campus located on Clifton Road,
all CLIAC attendees are required to register for the meeting online
at least 14 days in advance at http://www.cdc.gov/cliac/default.aspx
by clicking the ``Register for a Meeting'' link and completing all
forms according to the instructions given. Please complete all the
required fields before submitting your registration and submit no
later than August 16, 2011.
Providing Oral or Written Comments: It is the policy of CLIAC to
accept written public comments and provide a brief period for oral
public comments whenever possible. Oral Comments: In general, each
individual or group requesting to make an oral presentation will be
limited to a total time of five minutes (unless otherwise
indicated). Speakers must also submit their comments in writing for
inclusion in the meeting's Summary Report. To assure adequate time
is scheduled for public comments, individuals or groups planning to
make an oral presentation should, when possible, notify the contact
person below at least one week prior to the meeting date. Written
Comments: For individuals or groups unable to attend the meeting,
CLIAC accepts written comments until the date of the meeting (unless
otherwise stated); however, it is requested that comments be
submitted at least one week prior to the meeting date so that the
comments may be made available to the Committee for their
consideration and public distribution. Written comments, one hard
copy with original signature, should be provided to the contact
person below. Written comments will be included in the meeting's
Summary Report.
Contact Person for Additional Information: Nancy Anderson,
Chief, Laboratory Practice Standards Branch, Division of Laboratory
Science and Standards, Laboratory Science, Policy and Practice
Program Office (LSPPPO), Office of Surveillance, Epidemiology and
Laboratory Services, CDC, 1600 Clifton Road, NE., Mailstop F-11,
Atlanta, Georgia 30333; telephone (404) 498-2741; fax (404) 498-
2219; or via e-mail at [email protected].
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining
to announcements of meetings and other committee management
activities, for the Centers for Disease Control and Prevention, and
the Agency for Toxic Substances and Disease Registry.
Dated: June 30, 2011.
Elizabeth Millington,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2011-17009 Filed 7-6-11; 8:45 am]
BILLING CODE 4163-18-P